GGrantIndex
Sort

51,570 grants matching autoimmune disease

Novel CRISPR-Cas9 protein delivery to T cells in vivo by targeting CD7

$669,671
Guohua Yi · University Of Texas Hlth Ctr At Tyler · UG3 · FY2021 · AI

Clinical Diagnostic Studies and Treatment of Patients with Immune Deficiencies

$669,664
Suk De Ravin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Cell migration and wound repair

$669,616
Anna Huttenlocher · University Of Wisconsin-Madison · R35 · FY2021 · GM

Phase 1 Study of Autologous CD4LVFOXP3 in Participants with IPEX Syndrome [revised IND and clinical protocol to be submitted to FDA by 10/11/2021]

$669,615
Rosa Bacchetta · Stanford University · R01 · FY2024 · FD

CD103 engagement regulates intestinal IEL effector function

$669,586
Tessa Bergsbaken · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI

Social Factors, Epigenomics, and Lupus in African American women (SELA)

$669,569
Paula Sofia Ramos · Medical University Of South Carolina · R01 · FY2021 · MD

Role of the Intestinal Microbiota in ALS

$669,479
Howard L Weiner · Brigham And Women'S Hospital · R01 · FY2024 · NS

Nanofiber Scaffolds for Salivary Gland Regeneration

$669,454
Melinda Larsen · State University Of New York At Albany · R01 · FY2023 · DE

Proinflammatory B Cells Defined by TIM-4 in the Alloimmune Response

$669,277
David M Rothstein · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI

Project 3: Role of Novel Pathways in Regulating Allogeneic Immune Responses

$669,277
Bruce R. Blazar · Harvard Medical School · P01 · FY2019 · AI

Macrophage endocytosis in resolving lung inflammation

$669,193
Peter M Henson · National Jewish Health · R01 · FY2016 · HL

PRECLINICAL STRATEGIES FOR TOLERANCE TO ISLET ALLOGRAFTS

$669,192
University Of Miami School Of Medicine · R01 · FY2003 · DK

Identification and characterization of gut microbial bioactive molecules that determine predisposition to autoimmune disease and atopy

$669,124
Jon Clardy · Harvard Medical School · R01 · FY2020 · AT

Identification and characterization of gut microbial bioactive molecules that determine predisposition to autoimmune disease and atopy

$669,124
Jon Clardy · Harvard Medical School · R01 · FY2019 · AT

Identification and characterization of gut microbial bioactive molecules that determine predisposition to autoimmune disease and atopy

$669,124
Jon Clardy · Harvard Medical School · R01 · FY2018 · AT

Predicting Clinical Phenotypes in Crohn's Disease Using Machine Learning and Single-Cell 'omics

$669,097
Sana Syed · University Of Virginia · R01 · FY2024 · DK

The role of liver progenitor cells in liver regeneration

$669,086
Wolfram Goessling · Brigham And Women'S Hospital · R01 · FY2023 · DK

Targeting Kv1.3 potassium channels for neuro-immunomodulation in Alzheimer's Disease

$669,045
Srikant Rangaraju · Yale University · R01 · FY2024 · NS

Mechanisms of T cell persistence during chronic autoimmunity

$668,683
Maria Bettini · University Of Utah · R01 · FY2024 · AI

Survival and potential of insulin-deficient beta cells in type 1 diabetes

$668,675
Desmond Arthur Schatz · University Of Florida · U01 · FY2025 · DK

An experimentally-refined, dynamic gene regulatory network model of T-cell memory

$668,617
Artem Barski · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · AI

Defining the Role of Viral Infections and Autoantibodies in Chronic Obstructive Pulmonary Disease Progression

$668,611
Ingo Ruczinski · Johns Hopkins University · R01 · FY2025 · HL

Ion channels regulating plasma cell differentiation and humoral immunity

$668,605
Stefan Feske · New York University School Of Medicine · R01 · FY2024 · AI

Studies on Transfer RNA

$668,570
Dieter G Soll · Yale University · R01 · FY2009 · GM

Phase 1 Study of Autologous CD4LVFOXP3 in Participants with IPEX Syndrome [revised IND and clinical protocol to be submitted to FDA by 10/11/2021]

$668,482
Rosa Bacchetta · Stanford University · R01 · FY2022 · FD